Florida’s Republican Governor Ron DeSantis pledged to find a way to protect Floridians when Joe Biden’s White House recently announced that it was taking over the “equitable” distribution of necessary monoclonal COVID-19 treatments.
DeSantis has delivered on that promise, as it was reported last week that DeSantis’s administration had reached an agreement for Florida to acquire thousands of monoclonal antibody treatments directly from GlaxoSmithKline. The arrangement circumvents the artificial restrictions on supply put in place by Biden to punish DeSantis and Florida residents in need of life-saving treatments.
Florida had been receiving around 30,000 doses weekly before Biden cut the supply to about 18,000. The new agreement reached by DeSantis will add around 3,000 doses immediately.
DeSantis said that, unlike the federal government, his administration wants all residents who could benefit from the treatments to access them. He added that the state would “leave no stone unturned” in searching for treatments for Floridians and is encouraged by the agreement he has reached with GlaxoSmithKline.
Medical studies indicate that monoclonal antibody treatments allow more COVID patients to avoid inpatient hospital treatment when used early after infection. Chief of Lee Health Dr. Larry Antonucci said that monoclonal antibody treatments had been a “game-changer” in Florida. The treatments are vital to keeping patients out of the hospital and helping them get better quicker.
The GlaxoSmithKline treatment is similar to Regeneron, the monoclonal antibody treatment provided to President Trump in 2020. Federal regulators have insisted that Regeneron only be made available to the federal government.
DeSantis had previously claimed that the Biden administration took over distribution of Regeneron to target Republican states, including Florida. He added that Biden’s decision would cause people to “suffer as a result.”
Ron DeSantis press secretary Christina Pushaw recently told Fox News that it was “deeply disappointing” that the Biden administration would break a promise and cut the allocation of monoclonal antibody treatments being distributed to Florida to less than half of what is needed.